Valuation Update With 7 Day Price Move • May 08
Investor sentiment improves as stock rises 43% After last week's 43% share price gain to ₹652, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 15% over the past year. Reported Earnings • May 05
Full year 2026 earnings released: EPS: ₹19.20 (vs ₹3.91 loss in FY 2025) Full year 2026 results: EPS: ₹19.20 (up from ₹3.91 loss in FY 2025). Revenue: ₹2.96b (up 3.1% from FY 2025). Net income: ₹110.4m (up ₹132.8m from FY 2025). Profit margin: 3.7% (up from net loss in FY 2025). The move to profitability was primarily driven by higher revenue. New Risk • May 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 7.8% over the past year. Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₹3.15b market cap, or US$33.1m). 공시 • Apr 29
National Peroxide Limited to Report Q4, 2026 Results on Apr 30, 2026 National Peroxide Limited announced that they will report Q4, 2026 results on Apr 30, 2026 Board Change • Mar 31
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. CEO & Director Rajiv Arora is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Buy Or Sell Opportunity • Feb 24
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 27% to ₹402. The fair value is estimated to be ₹506, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.8% over the last year. Meanwhile, the company became loss making. Reported Earnings • Feb 06
Third quarter 2026 earnings released: EPS: ₹3.19 (vs ₹2.64 loss in 3Q 2025) Third quarter 2026 results: EPS: ₹3.19 (up from ₹2.64 loss in 3Q 2025). Revenue: ₹699.9m (up 13% from 3Q 2025). Net income: ₹18.3m (up ₹33.5m from 3Q 2025). Profit margin: 2.6% (up from net loss in 3Q 2025). 공시 • Jan 22
National Peroxide Limited to Report Q3, 2026 Results on Jan 28, 2026 National Peroxide Limited announced that they will report Q3, 2026 results on Jan 28, 2026 Reported Earnings • Nov 05
Second quarter 2026 earnings released: EPS: ₹0.67 (vs ₹2.64 loss in 2Q 2025) Second quarter 2026 results: EPS: ₹0.67 (up from ₹2.64 loss in 2Q 2025). Revenue: ₹699.5m (up 13% from 2Q 2025). Net income: ₹3.86m (up ₹19.0m from 2Q 2025). Profit margin: 0.6% (up from net loss in 2Q 2025). 공시 • Oct 29
National Peroxide Limited to Report Q3, 2026 Results on Nov 03, 2025 National Peroxide Limited announced that they will report Q3, 2026 results on Nov 03, 2025 공시 • Jul 30
National Peroxide Limited, Annual General Meeting, Sep 04, 2025 National Peroxide Limited, Annual General Meeting, Sep 04, 2025, at 15:30 Indian Standard Time. Reported Earnings • Jul 30
First quarter 2026 earnings released: EPS: ₹1.55 (vs ₹5.35 in 1Q 2025) First quarter 2026 results: EPS: ₹1.55 (down from ₹5.35 in 1Q 2025). Revenue: ₹686.8m (down 22% from 1Q 2025). Net income: ₹8.90m (down 71% from 1Q 2025). Profit margin: 1.3% (down from 3.5% in 1Q 2025). The decrease in margin was driven by lower revenue. 공시 • Jul 24
National Peroxide Limited to Report Q1, 2026 Results on Jul 29, 2025 National Peroxide Limited announced that they will report Q1, 2026 results on Jul 29, 2025 New Risk • Jun 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 14% over the past year. Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (7.9% average weekly change). Market cap is less than US$100m (₹4.22b market cap, or US$48.8m). 공시 • May 01
National Peroxide Limited to Report Q4, 2025 Results on May 06, 2025 National Peroxide Limited announced that they will report Q4, 2025 results on May 06, 2025 공시 • Mar 19
National Peroxide Limited Announces Resignation of Munish Bakshi as Vice President - Marketing & Sales, with Effect from April 11, 2025 National Peroxide Limited informed that Mr. Munish Bakshi, Vice President - Marketing & Sales of the Company, has given a notice of resignation from the post of Vice President - Marketing & Sales to pursue another opportunity. Resignation: To pursue other career opportunity. Cessation is with effect from 11th April, 2025. 공시 • Jan 17
National Peroxide Limited to Report Q3, 2025 Results on Jan 23, 2025 National Peroxide Limited announced that they will report Q3, 2025 results on Jan 23, 2025 공시 • Oct 24
National Peroxide Limited to Report Q2, 2025 Results on Oct 29, 2024 National Peroxide Limited announced that they will report Q2, 2025 results on Oct 29, 2024 공시 • Aug 02
National Peroxide Limited Recommends Dividend for the Year Ended March 31, 2024 National Peroxide Limited at its board meeting held on May 09, 2024 had recommended payment of dividend at 125%, that is INR 12.50 per Equity Share of INR 10 each for the year ended March 31, 2024 subject To Approve the Members in the upcoming Annual General Meeting of the Members to be held on August 27, 2024. Final Dividend if declared, will be paid within the timelines prescribed under the law. The Board of Directors at its meeting held on July 31, 2024, approved closure of Register of Members and Share Transfer Books of the Company from August 21, 2024 to August 27, 2024 (both days inclusive) for the purpose of AGM and determining names of members entitled to receive Dividend to be declared at the AGM. Hence, the record date for the AGM and final dividend is August 20, 2024. 공시 • Aug 01
National Peroxide Limited, Annual General Meeting, Aug 27, 2024 National Peroxide Limited, Annual General Meeting, Aug 27, 2024. 공시 • Jul 25
National Peroxide Limited to Report Q1, 2025 Results on Jul 31, 2024 National Peroxide Limited announced that they will report Q1, 2025 results on Jul 31, 2024